Literature DB >> 15866163

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.

Theo P Hill1, Daniela Später, Makoto M Taketo, Walter Birchmeier, Christine Hartmann.   

Abstract

Osteoblasts and chondrocytes are involved in building up the vertebrate skeleton and are thought to differentiate from a common mesenchymal precursor, the osteo-chondroprogenitor. Although numerous transcription factors involved in chondrocyte and osteoblast differentiation have been identified, little is known about the signals controlling lineage decisions of the two cell types. Here, we show by conditionally deleting beta-catenin in limb and head mesenchyme that beta-catenin is required for osteoblast lineage differentiation. Osteoblast precursors lacking beta-catenin are blocked in differentiation and develop into chondrocytes instead. In vitro experiments demonstrate that this is a cell-autonomous function of beta-catenin in an osteoblast precursor. Furthermore, detailed in vivo and in vitro loss- and gain-of-function analyses reveal that beta-catenin activity is necessary and sufficient to repress the differentiation of mesenchymal cells into Runx2- and Sox9-positive skeletal precursors. Thus, canonical Wnt/beta-catenin signaling is essential for skeletal lineage differentiation, preventing transdifferentiation of osteoblastic cells into chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866163     DOI: 10.1016/j.devcel.2005.02.013

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  450 in total

1.  Mediation of osteogenic differentiation of human mesenchymal stem cells on titanium surfaces by a Wnt-integrin feedback loop.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Jung Hwa Park; Ginger R Dunn; David A Haithcock; Christine E Wasilewski; Barbara D Boyan; Zvi Schwartz
Journal:  Biomaterials       Date:  2011-06-01       Impact factor: 12.479

2.  Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.

Authors:  Luke H Hoeppner; Frank J Secreto; David F Razidlo; Tiffany J Whitney; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

3.  A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.

Authors:  Filemon Dela Cruz; Melissa Terry; Igor Matushansky
Journal:  Differentiation       Date:  2012-03-08       Impact factor: 3.880

Review 4.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 5.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

Review 6.  Osteoblastogenesis regulation signals in bone remodeling.

Authors:  C Zuo; Y Huang; R Bajis; M Sahih; Y-P Li; K Dai; X Zhang
Journal:  Osteoporos Int       Date:  2012-06       Impact factor: 4.507

7.  Phosphate regulates chondrogenesis in a biphasic and maturation-dependent manner.

Authors:  Biming Wu; Emily K Durisin; Joseph T Decker; Evran E Ural; Lonnie D Shea; Rhima M Coleman
Journal:  Differentiation       Date:  2017-05-08       Impact factor: 3.880

8.  Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.

Authors:  Rongrong Zhang; Babatunde O Oyajobi; Stephen E Harris; Di Chen; Christopher Tsao; Hong-Wen Deng; Ming Zhao
Journal:  Bone       Date:  2012-09-29       Impact factor: 4.398

Review 9.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

10.  Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model.

Authors:  Baoli Wang; Hongting Jin; Mei Zhu; Jia Li; Lan Zhao; Yejia Zhang; Dezhi Tang; Guozhi Xiao; Lianping Xing; Brendan F Boyce; Di Chen
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.